Clinical Trial Update: TIcaGrEloR and ABSORB Bioresorbable Vascular Scaffold Implantation for Recovery of Vascular Function After Successful Chronic Total Occlusion Recanalization [Phase 4]

View source ↗

Summary

Phase 4 trial update on TIcaGrEloR and ABSORB bioresorbable vascular scaffold for recovery of vascular function after successful CTO recanalization.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Total Occlusion of Coronary Arteries

Drugs mentioned

• ABSORB (null)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Hospital Clinic of Barcelona | Conditions: Patients Who Are Scheduled to Undergo a PCI (Percutaneous Coronary Intervention) for CTO (Chronic Total Occlusion) | Phase 4 | Status: COMPLETED